A.WoodR.LeithA.PiercyJ.HigginsV
Chen VL, Kuppa A, Oliveri A, et al
By resolving the underlying steatosis and reducing the chronic inflammatory burden, GLP-1 RAs reinforce their potential as powerful anticancer agents across the full spectrum of SLD
Medication quality and source
For example, one extensive review of semaglutides safety discusses the incidence of pancreatitis in study participants, as well as the potential link between GLP-1 RAs and pancreatic cancer.16 Its a sensible thing to study considering these drugs effect on the pancreas, and cases of pancreatitis were present in several studies, but researchers note that the incidence isnt meaningfully higher than that of the general population outside the study group
The EMPA-KIDNEY, Collaborative G, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R
